FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for Levothyroxine Sodium from Mylan Pharmaceuticals Inc. (ANDA 076187).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Hypothyroidism
• Goiter
• Hypothyroidism

Drugs mentioned

• LEVOTHYROXINE SODIUM (levothyroxine sodium)

Snippet

SUPPL AP for LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM)